Cognitive changes in multiethnic Asian breast cancer patients: A focus group study

Annals of Oncology

Volumn 23, Issue 10, 2012, Pages 2547-2552

  Cheung, Y T ^a   Shwe, M ^a   Tan, Y P ^b   Fan, G ^b   Ng, R ^b   Chan, A ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Chemobrain; Chemotherapy; Cognitive function; Focus group; Psychooncology; Qualitative

Indexed keywords

ADULT; AGING; ANXIETY; ARTICLE; ASIAN; BREAST CANCER; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; COPING BEHAVIOR; DECISION MAKING; DISEASE SEVERITY; EPISODIC MEMORY; ETHNICITY; FATIGUE; FEMALE; HUMAN; MOOD CHANGE; PERCEPTION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SOCIAL WORKER;

EID: 84984586932     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds029     Document Type: Article

References (28)

1. Cheung YT, Chui WK, Chan A. Neuro-cognitive impairment in breast cancer patients: pharmacological considerations. Crit Rev Oncol Hematol 2011. published on October 19, 2011. doi:10.1016/j.critrevonc.2011.09.001.
2. Vardy J. Cognitive function in breast cancer survivors. Cancer Treat Res 2009; 151: 387-419.
3. Vardy J, Wefel JS, Ahles T et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008; 19 (4): 623-629.
4. Schagen SB, Vardy J. Cognitive dysfunction in people with cancer. Lancet Oncol 2007; 8 (10): 852-853.
5. Hurria A, Somlo G, Ahles T. Renaming "chemobrain". Cancer Invest 2007; 25 (6): 373-377.
6. Pullens MJJ, De Vries J, Roukema JA. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology 2010; 19 (11): 1127-1138.
7. Reid-Arndt SA, Hsieh C, Perry MC. Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psychooncology 2010; 19 (5): 535-544.
8. Ketay S, Aron A, Hedden T. Culture and attention: evidence from brain and behavior. Prog Brain Res 2009; 178 (C): 79-92.
9. Wang Q. Are Asians forgetful? Perception, retention, and recall in episodic remembering. Cognition 2009; 111 (1): 123-131.
10. Schagen SB, Das E, van Dam FS. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psychooncology 2009; 18 (6): 674-678.
11. Attride-Stirling J. Thematic networks: an analytic tool for qualitative research. Qual Res 2001; 1 (3): 385-405.
12. Martin PY, Turner BA. Grounded theory and organizational research. J Appl Behav Sci 1986; 22 (2): 141-157.
13. Hudong Wiki. -" Chemobrain". 2011; http://www.hudong.com/ wiki/%E5%8C%96%E7%96%97%E8%84%91 (20 February 2012, date last accessed).
14. Shih V, Chiang J, Chan A. Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients. Ann Oncol 2009; 20 (4): 752-757.
15. Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv 2009; 3 (4): 223-232.
16. Munir F, Burrows J, Yarker J et al. Women's perceptions of chemotherapyinduced cognitive side affects on work ability: a focus group study. J Clin Nurs 2010; 19 (9-10): 1362-1370.
17. Chan E, Tan M, Xin J et al. Interactions between traditional Chinese medicines and Western therapeutics. Curr Opin Drug Discov Devel 2010; 13 (1): 50-65.
18. Holland J, Andersen B, Breitbart W et al. NCCN Clinical Practice Guidelines in Oncology: Distress Management, Version 1 2012; http://www.nccn.org/ professionals/physician_gls/PDF/distress.pdf (20 February 2012, date last accessed).
19. Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 2011; 12 (7): 703-708.
20. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982; 21 (Pt 1): 1-16.
21. Cella DF, Tulsky DS, Gray G et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11 (3): 570-579.
22. Oh B, Butow PN, Mullan BA et al. Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Support Care Cancer 2011; June 19 [Epub ahead of print], doi:10.1007/s00520-011-1209-6.
23. Cheng ST, Chan ACM, Yu ECS. An exploratory study of the effect of mahjong on the cognitive functioning of persons with dementia. Int J Geriatr Psychiatry 2006; 21 (7): 611-617.
24. Shennan C, Payne S, Fenlon D. What is the evidence for the use of mindfulnessbased interventions in cancer care? A review. Psychooncology 2011; 20 (7): 681-697.
25. Lees J, Chan A. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol 2011; 12 (13): 1249-1257.
26. Tam-McDevitt J. Polypharmacy, aging, and cancer. Oncology (Williston Park) 2008; 22 (9): 1052-1055.
27. Pirl WF, Muriel A, Hwang V et al. Screening for psychosocial distress: a national survey of oncologists. J Support Oncol 2007; 5 (10): 499-504.
28. Söllner W, DeVries A, Steixner E et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?. Br J Cancer 2001; 84 (2): 179-185.